Fidaxomicin for Clostridioides difficile infection in patients with inflammatory bowel disease: a multicenter retrospective cohort study - Top-Institutions - MDSpire

Fidaxomicin for Clostridioides difficile infection in patients with inflammatory bowel disease: a multicenter retrospective cohort study

  • By

  • Daniele Noviello

  • María Chaparro

  • Chiara Viganò

  • Andreas Blesl

  • Brigida Barberio

  • Henit Yanai

  • Ambrogio Orlando

  • Rocío Ferreiro-Iglesias

  • Cristina Bezzio

  • Alessandra Zilli

  • Tamás Molnár

  • Cristian Gheorghe

  • Francesco Conforti

  • Tommaso Innocenti

  • Simone Saibeni

  • Peter Bossuyt

  • Raquel Oliveira

  • Anna Maria Carvalhas Gabrielli

  • Alessandra Losco

  • Sophie Vieujean

  • Enrico Tettoni

  • Lorena Pirola

  • Silvia Calderone

  • Maya Kornowski Cohen

  • Gabriele Dragoni

  • Timo Rath

  • Manuel Barreiro-de Acosta

  • Edoardo Vincenzo Savarino

  • Javier P Gisbert

  • Maurizio Vecchi

  • Raja Atreya

  • Flavio Caprioli

  • April 1, 2025

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Gastroenterology
    • Infectious Diseases
    • Clinical Research

  • #2

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Gastroenterology
    • Infectious Diseases

  • #3

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Gastroenterology
    • Infectious Diseases
    • Microbiology

  • #4

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Gastroenterology
    • Infectious Diseases

  • #5

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Gastroenterology
    • Infectious Diseases

Original Source(s)

Fidaxomicin for Clostridioides difficile infection in patients with inflammatory bowel disease: a multicenter retrospective cohort study

  • by Daniele Noviello, María Chaparro, Chiara Viganò, Andreas Blesl, Brigida Barberio, Henit Yanai, Ambrogio Orlando, Rocío Ferreiro-Iglesias, Cristina Bezzio, Alessandra Zilli, Tamás Molnár, Cristian Gheorghe, Francesco Conforti, Tommaso Innocenti, Simone Saibeni, Peter Bossuyt, Raquel Oliveira, Anna Maria Carvalhas Gabrielli, Alessandra Losco, Sophie Vieujean, Enrico Tettoni, Lorena Pirola, Silvia Calderone, Maya Kornowski Cohen, Gabriele Dragoni, Timo Rath, Manuel Barreiro-de Acosta, Edoardo Vincenzo Savarino, Javier P Gisbert, Maurizio Vecchi, Raja Atreya, Flavio Caprioli

  • April 1, 2025

Related Content

Ethosuximide vs Placebo for IBS Pain

Randomized trial found no improvement in abdominal pain and higher discontinuation rates with the calcium channel blocker.

Refining Vancomycin Use in Early CDI

A modified dosing approach could reshape recurrence prevention strategies.

Urologic malignancy risk with chronic tumor necrosis factor-alpha inhibitor (TNF-I) exposure: a multicenter, retrospective cohort study